Optura, an AI orchestration platform for healthcare enterprises, has raised $17.5M in Series A funding led by Salesforce Ventures and Echo Health Ventures. The platform uses a proprietary ROAI™ methodology to prioritize AI use cases, build agents from workflows, and track returns through real-time monitoring of costs, performance, and outcomes. The capital will scale the platform amid rising demand for measurable AI results in payers, providers, and life sciences.
Healthcare AI Funding Tops $7.4B
Optura's raise aligns with a $7.4B surge in healthcare AI funding during Q1 2026 per Citybiz. Recent activity includes Enzo Health securing $20M in May 2026 to advance safe AI for clinicians. This wave reflects a shift from experimentation to production-scale deployments requiring governance and ROI proof, where Optura's full-stack approach integrates data, prioritization, and measurement.
95% of AI Pilots Deliver No Value
Healthcare organizations face paralysis in AI adoption, with 95% of GenAI pilots failing to produce measurable outcomes according to Optura's announcement. Despite $18B in planned U.S. healthcare AI spend for 2026 via SVB, trust issues stem from unproven returns rather than technical limitations. Current solutions leave enterprises stuck in "pilot purgatory," unable to scale or justify investments to boards.
ROAI Framework Ends Pilot Purgatory
Optura's platform comprises Librarian for data integration, Analyst for use case prioritization via Value & Viability Matrix, Generator for AI agent creation, and Operator for ongoing ROAI tracking. This orchestrates AI across complex, regulated environments, simulating impact pre-deployment and verifying hard-dollar savings post-launch. Customers like Prime Therapeutics, Independence Blue Cross, and Ardent Health have managed $2.1B+ in AI initiatives, generating $120M+ in value at 500-700% ROAI per Fierce Healthcare.
As Michael Hollis, President, noted:
"We both found there was an absolute paralysis in the market related to AI adoption. It's less about the ability for AI to technically perform. It's not a technological problem, it's a trust problem."
Salesforce Backs Enterprise AI Scale
Salesforce Ventures brings $6B+ in experience across 700+ companies, including AI leaders like Anthropic and health tech like Lyra Health from investor site. Echo Health Ventures adds payer expertise, with portfolio wins like Codoxo in AI payment integrity. Participation from Susa Ventures, Matrix Partners, and HC9 Ventures signals conviction in Optura's shift from hype to accountable AI, unlocking enterprise adoption.
Katie Thiry of Salesforce Ventures stated:
"Healthcare organizations are under growing pressure to move beyond AI experimentation and deliver measurable business outcomes."
AI Healthcare Market Grows to $50B
The AI in healthcare market stands at $36.67B in 2025, projected to reach $50.7B by 2026 at 38% CAGR per Grand View Research. Trends emphasize agentic AI, governance, and ROI scaling amid clinician shortages and cost pressures. Optura positions as the measurement layer for this expansion, tracking 250+ use cases and serving 8,000+ users with $3.7M+ ARR and $18M+ pipeline via company traction.
Founders Bring Cigna Emids Expertise
Co-founder Andy Fanning, ex-VP of AI and Automation at Cigna, pairs with Michael Hollis, former President of Emids, to deliver healthcare ops credibility from company about. Their track record addresses the 95% pilot failure by focusing on operationalization from day one. Recent hires like SVP Jon Hilton (ex-LBMC, EY) and VP Katy Feldner (ex-Elevance Health) bolster scaling per recent activity.